Connor, Clark & Lunn Investment Management Ltd. Astrazeneca PLC Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$26 Billion
Q2 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 20,495 shares of AZN stock, worth $1.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,495

Previous 31,082 34.06%

Holding current value

$1.53 Million

Previous $2.28 Million 37.3%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$64.87 - $75.0 $686,778 - $794,025	-10,587 Reduced 34.06%	20,495 $1.43 Million
Q1 2025 May 12, 2025	BUY	$65.37 - $77.96 $379,603 - $452,713	5,807 Added 22.98%	31,082 $2.28 Million
Q4 2024 Feb 10, 2025	BUY	$63.2 - $79.58 $471,788 - $594,064	7,465 Added 41.91%	25,275 $1.66 Million
Q3 2024 Nov 08, 2024	BUY	$76.67 - $87.62 $385,036 - $440,027	5,022 Added 39.27%	17,810 $1.39 Million
Q2 2024 Aug 09, 2024	BUY	$66.81 - $80.83 $188,871 - $228,506	2,827 Added 28.38%	12,788 $997,000
Q1 2024 May 09, 2024	SELL	$61.03 - $69.57 $13,975 - $15,931	-229 Reduced 2.25%	9,961 $674,000
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $76,124 - $85,214	-1,230 Reduced 10.77%	10,190 $686,000
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $26,264 - $29,038	-405 Reduced 3.42%	11,420 $773,000
Q2 2023 Aug 10, 2023	BUY	$69.91 - $75.81 $39,499 - $42,832	565 Added 5.02%	11,825 $846,000
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $4.45 Million - $5.05 Million	-70,498 Reduced 86.23%	11,260 $781,000
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $8.88 Million - $11.5 Million	-163,718 Reduced 66.69%	81,758 $5.54 Million
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $32.1 Million - $82.2 Million	-605,306 Reduced 71.15%	245,476 $13.5 Million
Q2 2022 Aug 05, 2022	BUY	$59.26 - $71.14 $50 Million - $60.1 Million	844,177 Added 12780.88%	850,782 $56.2 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $1.28 Million - $1.54 Million	-22,925 Reduced 77.63%	6,605 $438,000
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $1.6 Million - $1.88 Million	29,530 New	29,530 $1.72 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $5.86 Million - $6.74 Million	-110,350 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $4.76 Million - $6.1 Million	110,350 New	110,350 $5.84 Million
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $4.53 Million - $5.13 Million	-112,900 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$37.28 - $41.68 $2.84 Million - $3.18 Million	76,200 Added 207.63%	112,900 $4.66 Million
Q1 2019 May 08, 2019	SELL	$35.49 - $43.02 $1.42 Million - $1.72 Million	-40,000 Reduced 52.15%	36,700 $1.48 Million
Q4 2018 Feb 12, 2019	BUY	$36.86 - $41.49 $2.83 Million - $3.18 Million	76,700 New	76,700 $2.91 Million
Q3 2017 Nov 14, 2017	SELL	$28.96 - $34.0 $3.65 Million - $4.29 Million	-126,100 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	126,100	126,100 $4.3 Million

Others Institutions Holding AZN

# of Institutions

1,421

Shares Held

507M

Call Options Held

9.82M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $231B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Astrazeneca PLC Transaction History